Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy.
Type
Journal articlePermalink
https://hdl.handle.net/10161/20332Published Version (Please cite this version)
10.1161/CIRCULATIONAHA.110.954446Publication Info
(2010). Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy.
Circulation, 122(23). pp. 2441-2450. 10.1161/CIRCULATIONAHA.110.954446. Retrieved from https://hdl.handle.net/10161/20332.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Andrew Paul Landstrom
Associate Professor of Pediatrics
Dr. Landstrom is a physician scientist who specializes in the care of children and
young adults with arrhythmias, heritable cardiovascular diseases, and sudden unexplained
death syndromes. As a clinician, he is trained in pediatric cardiology with a focus
on arrhythmias and genetic diseases of the heart. He specializes in caring for patients
with heritable arrhythmia (channelopathies) such as long QT syndrome, Brugada syndrome,
catecholaminergic polymorphic ventricular tachycardia,
Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info